Description
| Specialty | RIVA |
|---|---|
| Dosage | 20 mg |
| Form | Film-coated tablet |
| Presentation | Box of 10 |
| Primary Packaging | Blister |
| Specification | ALU, PVC, PVDC |
| INN (International Nonproprietary Name) | RIVAROXABAN |
| VEIC Classification | Essential |
| Therapeutic Class | BLOOD AND HEMATOPOIETIC ORGANS |
| Sub-Class | ANTITHROMBOTIC AGENTS |
| Laboratory | PHILADELPHIA PHARMA |
| Schedule/Table | A |
| Shelf Life | 24 (months) |
| Generic/Brand Name (Princeps) | Generic |
| Marketing Authorization Number (MA) | 9353255 |
| Marketing Authorization Date | 2020-06-29 |
| Product Range | Cardio-Metabolic Range |







Reviews
There are no reviews yet.